Sample Preparation

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

SHIMSEN Styra C18-U is an octadecyl bonded silica cartridge and can retain target compounds by non-polar interaction. The phase is non-endcapped which enhances retention of polar compounds. Retention mechanism: Non-polar interaction (primary) , polar interaction (secondary) Matrix: Particle size 50 μm, pore size 60 Å Spherical silica particles with a specific surface area of 500 m2/g Function groups: Octadecyl Endcapped: No Carbon load (C%): 17%   Application: C18-U is a non-endcapped version of the octadecyl bonded phases. The residual silanols on the surface of the silica gel matrix have polar interaction with polar compounds, which can enhance retention of polar compounds, especially amine compounds (such as tetracycline drugs), and is suitable for the extraction of polar and non-polar compounds. Part Number Specification Pack Size 380-00876-01 60 mg / 3 mL 50 380-00876-02 500 mg / 20 mL 20 380-00876-03 500 mg / 6 mL 30 380-00876-04 500 mg / 3 mL 50 380-00876-05 50 mg / 1 mL 100 380-00876-06 5 g / 20 mL 20 380-00876-07 200 mg / 3 mL 50 380-00876-08 2 g / 12 mL 20 380-00876-09 1000 mg / 6 mL 30 380-00876-10 100 mg / 1 mL 100 380-00876-11 10 g / 60 mL 10  

• LOGIN
• 

• LOGIN
• 

• LOGIN
•